Abstract

Background: While some therapies implemented for newly diagnosed Diabetes Mellitus (DM) or impaired Glucose Tolerance (IGT) are effective in preventing cardiovascular events, investigations of coronary plaque in patients with newly diagnosed DM or IGT are lacking. Methods: We evaluated 96 patients with acute coronary syndrome. The External Elastic Membrane (EEM), Lumen Cross-Sectional Area (CSA), plaque CSA, and plaque burden in the Left Anterior Descending (LAD) artery proximal to the lesion, diagnosed as normal by Coronary Angiography (CAG), were measured using Intravascular Ultrasound (IVUS). Patients were divided according to DM status (DM=35, non-DM=61). Non-DM patients underwent a 75g Oral Glucose Tolerance Test (OGTT) and were further divided into abnormal glucose tolerance (AGT; n=29) and Normal Glucose Tolerance (NGT) groups (n=32). Results: Quantitative Coronary Angiography (QCA) showed no significant differences in EEM or vessel diameter between groups. However, the lumen CSA was significantly smaller in the DM group than in the NGT group. The plaque CSA and plaque burden were significantly greater in the DM and AGT groups than in the NGT group. Total insulin and glucose values and insulin and glucose values at 120 min after the OGTT correlated with plaque CSA; insulin values at 120 min after the OGTT showed the strongest correlation (R=0.505, P<0.01). Conclusions: Coronary plaque was identified among newly diagnosed DM or IGT patients even when the CAG appeared normal, suggesting that preventive measures against atherosclerosis should be initiated prior to DM development.

Highlights

  • Diabetes mellitus (DM) has been identified as a risk factor for cardiovascular disease

  • The lumen cross-sectional area (CSA) measured 7.4 ± 2.8mm2 in the Diabetes Mellitus (DM) group, 8.4 ± 2.3mm2 in the abnormal glucose tolerance (AGT) group, and 9.2 ± 3.3mm2 in the Normal Glucose Tolerance (NGT) group, indicating that the lumen CSA was significantly smaller in the DM group than in the NGT group (P=0.0140; Figure 4A)

  • CSA was significantly greater in patients with AGT than in those with NGT, that there was no significant difference in the plaque CSA between patients with AGT and those with DM, and that insulin levels at 120 min after the 75-g Oral Glucose Tolerance Test (OGTT) correlated with plaque CSA in patients with AGT and NGT

Read more

Summary

Introduction

Diabetes mellitus (DM) has been identified as a risk factor for cardiovascular disease. Mortality risk is 2–3 times greater in patients with DM than in those without [1,2]. Retrospective studies have demonstrated that patients with DM have more extensive coronary plaque compared with those without [3,4]. Abnormal glucose metabolism, such as that seen in patients with DM or impaired glucose tolerance (IGT), is recognized in over two-thirds of patients with cardiovascular disease such as acute myocardial infarction or angina pectoris [2,6,7]. While some therapies implemented for newly diagnosed Diabetes Mellitus (DM) or impaired Glucose Tolerance (IGT) are effective in preventing cardiovascular events, investigations of coronary plaque in patients with newly diagnosed DM or IGT are lacking

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call